DEMİRAY, A. Et Al. 2024. Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease. CARDIORENAL MEDICINE , vol.14, no.1 , 167-177.

DEMİRAY, A., OZAN, R., ÖZAYTÜRK, S. G., İMAMOĞLU, H., ZARARSIZ, G., SİPAHİOĞLU, M. H., ... TOKGÖZ, B.(2024). Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease. CARDIORENAL MEDICINE , vol.14, no.1, 167-177.

DEMİRAY, ALPARSLAN Et Al. "Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease," CARDIORENAL MEDICINE , vol.14, no.1, 167-177, 2024

DEMİRAY, ALPARSLAN Et Al. "Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease." CARDIORENAL MEDICINE , vol.14, no.1, pp.167-177, 2024

DEMİRAY, A. Et Al. (2024) . "Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease." CARDIORENAL MEDICINE , vol.14, no.1, pp.167-177.

@article{article, author={ALPARSLAN DEMİRAY Et Al. }, title={Evaluation of the Renal and Cardiovascular Effects of Long-Term Tolvaptan Treatment in Autosomal Dominant Polycystic Kidney Disease}, journal={CARDIORENAL MEDICINE}, year=2024, pages={167-177} }